Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Targeting JAK-STAT pathway in malignant and non-malignant cells in...
Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA
Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms ( Dr Ross Levine - Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2013
Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic...
Dr Valentin Goede - University Hospital of Cologne, Germany
Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia ( Dr Valentin Goede - University Hospital of Cologne, Germany )
18 Jun 2013
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma
Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
17 Jun 2013
Vemurafenib and ipilimumab for metastatic melanoma
Dr Caroline Robert - Institute Gustave Roussy, Paris, France
Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )
14 Jun 2013
Science behind phase I clinical trials: targeting tumour cell development...
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
Next generation of anti-cancer agents: data from ASCO 2013
Dr Sarah Blagden - Imperial College, London, UK
Next generation of anti-cancer agents: data from ASCO 2013 ( Dr Sarah Blagden - Imperial College, London, UK )
4 Jun 2013
Phase I study measures effect of ipilimumab and nivolumab combination in...
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Axillary radiotherapy provides alternative to invasive early stage breast...
Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam
Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery ( Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam )
3 Jun 2013
Comment on progression free survival in lung cancer patients and the GALAXY-1...
Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Paclitaxel dosing equally effective in preventing breast cancer progression
Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA
Paclitaxel dosing equally effective in preventing breast cancer progression ( Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Paclitaxel chemotherapy schedules equally effective for early-stage breast...
Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA
Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer ( Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA )
3 Jun 2013
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation